Pirmenol

Independent reference data for Pirmenol (CAS 68252-19-7), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Synonyms and trade names

PIRMENOL; 68252-19-7; DTXSID1043839; Pirmenolum; DTXCID9023839; RefChem:929350; cis-alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-2-pyridinemethanol monohydrochloride; VZ3B6ACV72; rel-4-((2S,6R)-2,6-Dimethylpiperidin-1-yl)-1-phenyl-1-(pyridin-2-yl)butan-1-ol; MFCD01758678; 4-((2R,6S)-2,6-dimethylpiperidin-1-yl)-1-phenyl-1-(pyridin-2-yl)butan-1-ol; 4-[(2r,6s)-2,6-dimethylpiperidin-1-yl]-1-phenyl-1-(pyridin-2-yl)butan-1-ol; 129885-19-4; 4-[(2S,6R)-2,6-dimethylpiperidin-1-yl]-1-phenyl-1-pyridin-2-ylbutan-1-ol; (+)-Pirmenol; (-)-Pirmenol

What the public record says

Pirmenol · CAS 68252-19-7 · C22H30N2O. UNII VZ3B6ACV72.

Source: PubChem / Wikidata; the batch COA governs where values differ.